DK1855711T3 - Use of BAFF to treat Th2 mediated conditions - Google Patents

Use of BAFF to treat Th2 mediated conditions

Info

Publication number
DK1855711T3
DK1855711T3 DK06734022T DK06734022T DK1855711T3 DK 1855711 T3 DK1855711 T3 DK 1855711T3 DK 06734022 T DK06734022 T DK 06734022T DK 06734022 T DK06734022 T DK 06734022T DK 1855711 T3 DK1855711 T3 DK 1855711T3
Authority
DK
Denmark
Prior art keywords
baff
treat
mediated conditions
mediated
conditions
Prior art date
Application number
DK06734022T
Other languages
Danish (da)
Inventor
Charles Mackay
Fabienne Mackay
Susan Kalled
Original Assignee
Biogen Idec Inc
Garvan Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Inc, Garvan Inst Med Res filed Critical Biogen Idec Inc
Application granted granted Critical
Publication of DK1855711T3 publication Critical patent/DK1855711T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
DK06734022T 2005-01-28 2006-01-27 Use of BAFF to treat Th2 mediated conditions DK1855711T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64809805P 2005-01-28 2005-01-28
PCT/US2006/003127 WO2006081516A2 (en) 2005-01-28 2006-01-27 USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS

Publications (1)

Publication Number Publication Date
DK1855711T3 true DK1855711T3 (en) 2009-10-12

Family

ID=36741125

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06734022T DK1855711T3 (en) 2005-01-28 2006-01-27 Use of BAFF to treat Th2 mediated conditions

Country Status (9)

Country Link
US (1) US20080254030A1 (en)
EP (1) EP1855711B1 (en)
AU (1) AU2006209237B2 (en)
CA (1) CA2596276A1 (en)
DE (1) DE602006007323D1 (en)
DK (1) DK1855711T3 (en)
HK (1) HK1110803A1 (en)
NZ (1) NZ560285A (en)
WO (1) WO2006081516A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8212004B2 (en) * 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
PT2275449T (en) * 2000-06-16 2016-12-27 Human Genome Sciences Inc Antibodies that immunospecifically bind to blys
US7879328B2 (en) * 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
WO2002016411A2 (en) * 2000-08-18 2002-02-28 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
US9168286B2 (en) * 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
AU2006344395B2 (en) * 2005-10-13 2013-05-02 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive diseases
WO2007123765A2 (en) * 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
WO2010093993A2 (en) * 2009-02-12 2010-08-19 Human Genome Sciences, Inc. Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
US8735347B2 (en) 2011-02-02 2014-05-27 Children's Hospital Medical Center Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595721A (en) * 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
US6541224B2 (en) * 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US6689579B1 (en) * 1996-10-25 2004-02-10 Human Genome Sciences, Inc. Polynucleotides encoding neutrokine-α
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US20030175208A1 (en) * 1996-10-25 2003-09-18 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
US20030022239A1 (en) * 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20010010925A1 (en) * 1997-11-17 2001-08-02 Steven R. Wiley Methods of detecting target nucleic acids of tnf-delta
US20020055624A1 (en) * 1997-11-17 2002-05-09 Steven R. Wiley Tnf-delta ligand and uses thereof
US6297367B1 (en) * 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
US20030095967A1 (en) * 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
DE60004635T2 (en) * 1999-01-25 2004-06-09 Biogen, Inc., Cambridge BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY
US6475986B1 (en) * 1999-02-02 2002-11-05 Research Development Foundation Uses of THANK, a TNF homologue that activates apoptosis
WO2000068378A1 (en) * 1999-05-06 2000-11-16 National Jewish Medical And Research Center Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
EE05673B1 (en) * 1999-08-17 2013-08-15 Biogen, Inc. BAFF receptor (BCMA), an immunoregulatory agent
UA74798C2 (en) * 1999-10-06 2006-02-15 Байоджен Айдек Ма Інк. Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors
EP1259544B1 (en) * 2000-02-11 2011-08-24 Biogen Idec MA Inc. Heterologous polypeptide of the tnf family
US20040013674A1 (en) * 2001-04-27 2004-01-22 Christine Ambrose Taci as an anti-tumor agent
PT2275449T (en) * 2000-06-16 2016-12-27 Human Genome Sciences Inc Antibodies that immunospecifically bind to blys
US6475686B2 (en) * 2000-07-28 2002-11-05 Canon Kabushiki Kaisha Fixing method
WO2002016411A2 (en) * 2000-08-18 2002-02-28 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
UA83458C2 (en) * 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
DE60227285D1 (en) * 2001-12-21 2008-08-07 Immunex Corp RECOMBINANT POLYPEPTIDE
US20030211509A1 (en) * 2002-03-26 2003-11-13 Wiley Steven R. TNF-delta ligand and uses thereof

Also Published As

Publication number Publication date
US20080254030A1 (en) 2008-10-16
AU2006209237B2 (en) 2010-06-24
EP1855711B1 (en) 2009-06-17
EP1855711A2 (en) 2007-11-21
WO2006081516A3 (en) 2007-05-03
DE602006007323D1 (en) 2009-07-30
CA2596276A1 (en) 2006-08-03
WO2006081516A2 (en) 2006-08-03
NZ560285A (en) 2011-04-29
HK1110803A1 (en) 2008-07-25
AU2006209237A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
DK1855711T3 (en) Use of BAFF to treat Th2 mediated conditions
DK1720866T3 (en) Course of action
DK2500017T3 (en) Use of ketogenic compounds to treat age-related memory impairment
DK1942938T3 (en) Use of oligouronates to treat mucus hyperviscosity
ATE543816T1 (en) AZACYCLOAL CANDERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE
BRPI0811473A2 (en) HYDROSOLUBLE MAGNESIUM COMPOUNDS AS CLEANING AGENTS AND METHODS OF USE THEREOF.
DK1986633T3 (en) TREATMENT OF DUCHENNES MUSCLE DYSTROPHY
DK2056807T3 (en) Treatment of inflammatory diseases
DK1874821T3 (en) Combination of antibodies with glycocorticoids to treat cancer
DK2329012T3 (en) Treatment of stroke using isolated placental cells
BRPI0914682A2 (en) heteroaryl compounds and uses thereof
ES1063346Y (en) WALKER
DE602007011204D1 (en) MOUNTING OF FASTENING DEVICES
ATE476424T1 (en) DIAZEPANDERIVATES AS MODULATORS OF CHEMOKINE RECEPTORS
DE112007000789A5 (en) Use of Bora tetraazepentalene
DK3225251T3 (en) MODULATION OF PRO-NEUROTROPHIN ACTIVITY
DE602005023266D1 (en) AZABENZOFURANS-SUBSTITUTED THIOSCORES AS INHIBITORS OF VIRUS REPLICATION
DK2373927T3 (en) WASTE TREATMENT OF WASTE TREATMENT
DE502007000290D1 (en) New Uses of Nonenolide
BRPI0915394A2 (en) purification of modified cytokines
DK2111555T3 (en) DIAGNOSTICATION OF PRE-CLAMPSY
DK2358714T3 (en) ALKYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES
BRPI0813830A2 (en) PURIFICATION OF PEGUILATED POLYPEPTIDES
DK2117565T3 (en) APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
FI20065834A0 (en) Type of device